Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bipolar 1 Disorder”

291 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 291 results

Post-approval studies (Phase 4)Study completedNCT00402324
What this trial is testing

A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients

Who this might be right for
Bipolar I Disorder
Eli Lilly and Company 202
Large-scale testing (Phase 3)Study completedNCT00761761
What this trial is testing

Sensoril(Ashwaganhda)for Bipolar Disorder

Who this might be right for
Bipolar I DisorderBipolar II DisorderBipolar Disorder NOS
University of Pittsburgh 60
Large-scale testing (Phase 3)Study completedNCT01072630
What this trial is testing

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Who this might be right for
Depression
Cephalon 492
Large-scale testing (Phase 3)Study completedNCT00113594
What this trial is testing

Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder

Who this might be right for
SchizophreniaBipolar Disorder
Eli Lilly and Company 100
Not applicableUnknownNCT03192631
What this trial is testing

Financial Incentives to Improve Acceptance of Antipsychotic Injections

Who this might be right for
SchizophreniaSchizo Affective DisorderBipolar I Disorder
Focus Community Mental Health Team 20
Not applicableStudy completedNCT02050854
What this trial is testing

Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia

Who this might be right for
Bipolar 1 DisorderSchizophreniaMental Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 47
Not applicableStudy completedNCT02506322
What this trial is testing

Adjuvant Psychotherapy for Relapse Prevention in Early Adulthood (< 35 yr.) of Bipolar Disorder

Who this might be right for
Bipolar Disorder
University Hospital Tuebingen 318
Large-scale testing (Phase 3)Study completedNCT00150605
What this trial is testing

Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Validus Pharmaceuticals 50
Not applicableStudy completedNCT01998516
What this trial is testing

Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder

Who this might be right for
SchizophreniaBipolar I Disorder
Medical University Innsbruck 350
Early research (Phase 1)Ended earlyNCT00939887
What this trial is testing

Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET (Positron Emission Tomography)

Who this might be right for
Bipolar DisorderDepression
Pfizer 12
Large-scale testing (Phase 3)Looking for participantsNCT07172516
What this trial is testing

Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Who this might be right for
Bipolar DisorderBipolar DepressionBipolar I Disorder+1 more
Xenon Pharmaceuticals Inc. 400
Early research (Phase 1)Study completedNCT01094249
What this trial is testing

A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder

Who this might be right for
SchizophreniaBipolar DisorderPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 9
Not applicableStudy completedNCT04855409
What this trial is testing

Neuronal Integrity in Bipolar Depression

Who this might be right for
Bipolar I Disorder, Most Recent Episode Depressed
Mehmet Diyaddin Güleken 32
Not applicableLooking for participantsNCT06373016
What this trial is testing

Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder

Who this might be right for
Bipolar DisorderBipolar Disorder Type 1
Stony Brook University 100
Early research (Phase 1)Study completedNCT00321516
What this trial is testing

Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 20
Large-scale testing (Phase 3)Study completedNCT00253162
What this trial is testing

The Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol

Who this might be right for
Bipolar DisordersManic Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 439
Post-approval studies (Phase 4)Study completedNCT01588457
What this trial is testing

Sequential Multiple Assignment Treatment for Bipolar Disorder

Who this might be right for
Bipolar I DisorderBipolar II Disorder
The University of Texas Health Science Center at San Antonio 112
Post-approval studies (Phase 4)Study completedNCT00844857
What this trial is testing

Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Who this might be right for
Bipolar Depression
Eli Lilly and Company 291
Testing effectiveness (Phase 2)Looking for participantsNCT07288320
What this trial is testing

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

Who this might be right for
Bipolar I DisorderMania
Neurocrine Biosciences 150
Not applicableStudy completedNCT04812379
What this trial is testing

Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

Who this might be right for
Bipolar Disorder I
Otsuka Pharmaceutical Co., Ltd. 535
Load More Results